Skip to content

RoosterBio

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • High Volume hMSCs
      • XF hBM-MSCs
      • XF hUC-MSCs
      • XF RTP hBM-MSCs
      • Traditional hBM-MSCs
      • Traditional RTP hBM-MSCs
    • hMSC Bioprocess Media
      • XF hMSC Bioprocess Media
      • XF hMSC Bioreactor Feeds
      • XF hMSC Bioprocess Supplements & Reagents
      • Traditional hMSC Bioprocess Media
    • CliniControl Products
      • CliniControl High Volume hMSCs
      • CliniControl hMSC Bioprocess Media
      • CliniControl Extracellular Vesicle (EV) Production
    • Extracellular Vesicle (EV) Production
      • EV Collection Media
      • EV Supplements & Reagents
    • hMSC Kits
      • RoosterVial & RoosterNourish Test Kits
      • Donor Screening Test Kits
      • Bioreactor Starter Kits
      • Bioreactor Development Kits
      • Bioprinting Kits
      • Bioprinting RTP Kits
  • Services
    • Process Development Services
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Press Releases

RoosterBio Inc and Tissue Regeneration Therapeutics Inc Announce Alliance Around Scale-up Manufacturing of Umbilical Cord Tissue Perivascular Cell Technology

December 10, 2018

RoosterBio Submits U.S. FDA Master Files for CliniControl Line of Human Mesenchymal Stem/Stromal Cell Products.

November 9, 2018

RoosterBio Inc. Earns NIIMBL NOD With 2 Grant Awards for Regenerative Medicine Manufacturing.

October 11, 2018

RoosterBio Inc. Shares Innovation Insight at Biotech Week Boston.

August 30, 2018

RoosterBio Inc. Becomes Industry Partner in NSF-Funded Public-Private Cell Manufacturing Technologies Initiative.

June 13, 2018

A New Day Dawns for RoosterBio, Inc., FITCI Graduate.

February 27, 2018

RoosterBio Commercializes Industry’s First cGMP human Mesenchymal Stem Cell Banks for Widespread Manufacturing, Continuing to Revolutionize Regenerative Medicine.

January 25, 2018

RoosterBio selects GenCure as its preferred manufacturer to leverage its scalable technology platform, accelerating the initiation of first-in-man studies.

October 2, 2017

RoosterBio Launches New cGMP Stem Cell Product Portfolio, Maintaining Unwavering Commitment to Driving the Explosive Regenerative Medicine Industry.

September 14, 2017

Stem Cell Exomere Program announced by RoosterBio and Exopharm.

August 7, 2017
Previous 1 2 3 4 5 6 Next

Sidebar Navigation

Careers

Contact Us

Contact Information

RoosterBio, Inc.
Email: info@roosterbio.com Phone: +1 301-200-5366

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn
  • Email

Copyright © 2021 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Wood Street, Inc.